AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Geriatr Psychiatry 1:249-253, August 1993
© 1993 American Association for Geriatric Psychiatry
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herrmann, N.
Right arrow Articles by Eryavec, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Herrmann, N.
Right arrow Articles by Eryavec, G.

CLINICAL AND RESEARCH REPORT

Buspirone in the Management of Agitation and Aggression Associated With Dementia

Nathan Herrmann, M.D., F.R.C.P.C., and Goran Eryavec, M.D., F.R.C.P.C.

Sunnybrook Health Science Centre, University of Toronto Clinic, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5 Canada.

Buspirone, a nonbenzodiazepine anxiolytic, has been shown to decrease aggression in animal models and reduce agitation in a small number of patients with organic brain syndromes. An open pilot study was conducted to assess the usefulness of buspirone in managing agitation and aggression in elderly dementia patients. Sixteen patients, ages 65–89, with various types of dementia associated with severe agitation and aggression were treated with buspirone. Outcome was measured by the Clinical Global Impression Scale. Significant improvement was noted in six patients. Buspirone holds promise as a modestly effective and relatively safe alternative to neuroleptics in the management of agitation and behavioral disturbances associated with dementia. More systematic trials are indicated.




This article has been cited by other articles:


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
K. L. Lanctôt, N. Herrmann, and P. Mazzotta
Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia
J Neuropsychiatry Clin Neurosci, February 1, 2001; 13(1): 5 - 21.
[Abstract] [Full Text]


Home page
J Geriatr Psychiatry NeurolHome page
P. N. Tariot, L. S. Schneider, and I. R. Katz
Anticonvulsant and Other Non-neuroleptic Treatment of Agitation in Dementia
J Geriatr Psychiatry Neurol, October 1, 1995; 8(1): S28 - S39.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 1993 American Association for Geriatric Psychiatry